Seattle’s Aurion Biotech announced Wednesday that it received special designations from the U.S. Food and Drug Administration that should speed up the development of its treatment for a common disease… Read More
Seattle startup Cyrus Biotechnology is spinning out a business that will expand access to the company’s software technology, with the potential of supporting innovation in drug development, agriculture, synthetic biology… Read More
The ability to call your doctor’s office and speak to a live human appears to be a thing of the past as patients turn to digital communications. Yet options there… Read More
Vilya, a biotech startup built off technology developed at the Seattle-based Institute for Protein Design, announced an expanded $71 million Series A investment round. The 2-year-old company, which has operations… Read More
Researchers at Microsoft, Providence Health System and the University of Washington say they’ve developed a new artificial intelligence model for diagnosing cancer, based on an analysis of more than a… Read More
A-Alpha Bio will receive $14.5 million from the Department of Defense (DOD) to expand a project with a national lab to help prepare for future biological threats using the company’s… Read More
The Allen Institute for Immunology, a division of the Seattle-based Allen Institute, is teaming with Seattle Children’s Research Institute to launch a study aimed at understanding the origins of inflammatory… Read More
Seattle startup Dopl Technologies has developed a telerobotic ultrasound system intended to bring specialist care to patients in rural areas. Dopl’s mission is to eliminate the long distances that some… Read More
“Everyone poops,” declares the classic children’s book used by parents, including me, to help their kids understand what is a natural part of all animals’ lives. “Everyone poops — and… Read More
The University of Washington’s Institute for Protein Design is on a hot streak. New studies, companies and spinouts are emerging at a rapid clip from the research hub, propelled by… Read More
The culture of collaboration in the Pacific Northwest, the impact of AI on biopharma, and the shape of new business models driven by AI were all topics at a panel… Read More
Travis Rush grew up in the tiny seaside town of Gold Beach in Southern Oregon. With a population of only 1,576 — as was proudly proclaimed on the sign coming… Read More
Boston-based biotech company Vertex Pharmaceuticals agreed to acquire Seattle-based Alpine Immune Sciences for $65 per share, totaling about $4.9 billion in cash, a 38% premium over Alpine’s closing price on… Read More
A new test for the early detection of Alzheimer’s Disease — potentially even before symptoms are present — show that the diagnostic caught the neurodegenerative disease in 100% of the… Read More
ProfoundBio, a Seattle-based biotech firm developing drugs to treat ovarian and endometrial cancers, will be acquired by publicly traded Danish drugmaker Genmab in a $1.8 billion all-cash deal expected to… Read More
The news: Modulus Therapeutics, a Seattle-based cellular therapy company spun out of the Allen Institute of Artificial Intelligence (AI2) Incubator, has sold its cell therapy platform assets to the Boston… Read More
Researchers opened the doors Monday to the new Seattle Hub for Synthetic Biology, a collaboration between the Allen Institute, the Chan Zuckerberg Initiative and the University of Washington. The hub combines “academic creativity with… Read More
Sonoma Biotherapeutics on Monday hosted a ribbon cutting ceremony at its new research and development center and office space on Seattle’s waterfront. The biotech company, which has a second location… Read More
A good idea, preliminary data, and credentials in the field are all key components of landing a small business grant from the U.S. government to launch or expand a company.… Read More
More than 100 researchers — including a Nobel laureate — have signed on to a call for the scientific community to follow a set of safety and security standards when… Read More
Seattle biotech startup Phase Genomics is receiving $1.5 million from the Bill & Melinda Gates Foundation to fund research into two important areas: killing drug-resistant bacteria and battling methane-producing microorganisms… Read More
The Institute for Protein Design at the University of Washington is a startup factory, spinning out companies developing new protein-based therapeutics, industrial enzymes, materials, biosensors and more. A key to… Read More
A team working on prolonging the lifespan of transplant organs took home the top prize in the 9th annual Hollomon Health Innovation Challenge at the University of Washington. BioLegacy, made up of… Read More
PATH, the global health nonprofit, is moving to a new headquarters space in Seattle’s Fremont neighborhood after 15 years in South Lake Union. PATH announced a lease agreement Thursday with… Read More
Healionics, a Seattle-based medical technology company, raised $5.5 million in new financing aimed at helping the company complete an ongoing human trial and pursue regulatory clearance and commercialization of its… Read More
Biotech giant AstraZeneca has completed its $1.1 billion acquisition of Icosavax, a Seattle-based spinout from the University of Washington’s Institute for Protein Design.
ProfoundBio raised $112 million to support development of its pipeline of antibody-drug conjugates (ADCs), agents that recognize a molecular target via an antibody and deliver a toxin or other compound to… Read More
Just in time for new year’s resolutions, the Fred Hutchinson Cancer Center is releasing a free app that employs an artificial intelligence-powered chatbot to help people stop smoking. Through an… Read More
The halls at a recent meeting of biologists in Seattle were buzzing with more than just the usual excitement about spiders, bats, bees, elephants and other creatures. Researchers were also… Read More
A new Seattle-based startup called Avante confirmed that it raised $10 million in a seed funding round led by Fuse Venture Partners, saying it’s building a company with ambitions to… Read More
